SOPH

Healthcare Health Information Services

SOPHiA GENETICS SA

$7.34

+0.06 +0.82% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 7, 2026, live at 11:05 AM ET	7.34

Key Stats

Market Cap

615.79M

Avg Volume

541,913

EPS

-$1.16

52W High

$8.98

52W Low

$3.75

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-14.68

P/B Ratio

7.52

P/S Ratio

7.24

EV/EBITDA

-8.12

EV/Revenue

6.76

Margins

Gross Margin 66.6%

Operating Margin (86.0%)

Net Margin (93.9%)

EBITDA Margin (83.3%)

Growth & Returns

Revenue Growth (YoY)

27.2%

Return on Equity

(101.2%)

Return on Assets

(24.5%)

Liquidity & Leverage

Current Ratio

2.69

Quick Ratio

2.38

Debt / Equity

0.74

Total Cash

107.67M

Total Debt

61.83M

About

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom and a collaboration with AstraZeneca to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies. The company was incorporated in 2011 and is based in Rolle, Switzerland.